We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

174 hedge funds and large institutions have $865M invested in Collegium Pharmaceutical in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 74 increasing their positions, 59 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 59

3% more capital invested

Capital invested by funds: $843M → $865M (+$21.8M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

2.15% less ownership

Funds ownership: 113.43% → 111.28% (-2.2%)

2% less funds holding

Funds holding: 178 → 174 (-4)

19% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 21

82% less call options, than puts

Call options by funds: $239K | Put options by funds: $1.3M

Holders
174
Holders Change
-4
Holders Change %
-2.25%
% of All Funds
2.76%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
17
Increased
74
Reduced
59
Closed
21
Calls
$239K
Puts
$1.3M
Net Calls
-$1.06M
Net Calls Change
+$113K

Top Buyers

1
Pacer Advisors
Pacer Advisors
Pennsylvania
+$11.7M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$6.22M
3
BlackRock
BlackRock
New York
+$3.71M
4
Millennium Management
Millennium Management
New York
+$3.24M
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$2.54M

Top Sellers

1
MIIM
Mesirow Institutional Investment Management
Illinois
-$9.37M
2
RCMNY
Rubric Capital Management (New York)
New York
-$5.7M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$4.47M
4
LSV Asset Management
LSV Asset Management
Illinois
-$4.45M
5
TA
Tamarack Advisers
California
-$4.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$139M +$3.71M +162,645 +3%
RCMNY
2
Rubric Capital Management (New York)
New York
$71M -$5.7M -250,000 -7%
EAM
3
Eventide Asset Management
Massachusetts
$58.8M +$1.76K +77 +0%
Vanguard Group
4
Vanguard Group
Pennsylvania
$52.3M +$53.3K +2,339 +0.1%
Principal Financial Group
5
Principal Financial Group
Iowa
$35.3M -$92.4K -4,053 -0.3%
Pacer Advisors
6
Pacer Advisors
Pennsylvania
$28.9M +$11.7M +511,692 +66%
State Street
7
State Street
Massachusetts
$28.8M +$525K +23,027 +2%
Renaissance Technologies
8
Renaissance Technologies
New York
$26.2M -$2.34M -102,400 -8%
Invesco
9
Invesco
Georgia
$25.9M +$450K +19,740 +2%
CCM
10
Camber Capital Management
Massachusetts
$23.5M – – –
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$22.6M +$628K +27,537 +3%
Janus Henderson Group
12
Janus Henderson Group
United Kingdom
$19.7M -$4.47M -196,032 -18%
Victory Capital Management
13
Victory Capital Management
Texas
$16.7M -$680K -29,826 -4%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$15.9M +$483K +21,190 +3%
EA
15
Emerald Advisers
Pennsylvania
$15.4M -$2.61M -114,303 -14%
Massachusetts Financial Services
16
Massachusetts Financial Services
Massachusetts
$14.9M +$25.9K +1,136 +0.2%
Morgan Stanley
17
Morgan Stanley
New York
$13.2M +$911K +39,922 +7%
RSCM
18
Rock Springs Capital Management
Maryland
$12.6M -$2.01M -88,000 -14%
EMFAT
19
Emerald Mutual Fund Advisers Trust
Pennsylvania
$12.5M -$2.68M -117,680 -17%
Millennium Management
20
Millennium Management
New York
$10.8M +$3.24M +142,051 +42%
PCM
21
Peregrine Capital Management
Minnesota
$10.3M -$448K -19,636 -4%
Arrowstreet Capital
22
Arrowstreet Capital
Massachusetts
$9.62M +$1.33M +58,339 +16%
Assenagon Asset Management
23
Assenagon Asset Management
Luxembourg
$9.51M +$6.22M +272,565 +178%
Northern Trust
24
Northern Trust
Illinois
$9.03M -$55.6K -2,436 -0.6%
Marshall Wace
25
Marshall Wace
United Kingdom
$8.63M -$2.47M -108,180 -22%
1
2 3 4 5

COLL Hedge Fund Activity: Q3 2023 in Review

174 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q3 2023, worth a combined $865M — up 2.6% from $843M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of COLL and 17 opened new positions — a net loss of 4 holders — while 59 trimmed existing stakes and 74 added.

The largest buyer was Pacer Advisors, adding an estimated $11.7M. The largest seller was Mesirow Institutional Investment Management, exiting entirely with an estimated $9.37M sold.

  • 174 institutional investors held Collegium Pharmaceutical (COLL) as of Q3 2023, down from 178 in Q2 2023.
  • Funds reported $865M of Collegium Pharmaceutical stock for Q3 2023, up 2.6% quarter-over-quarter.
  • 17 funds opened new Collegium Pharmaceutical positions in Q3 2023 and 21 closed out, a net change of -4 holders.
  • The largest Collegium Pharmaceutical buyer in Q3 2023 was Pacer Advisors, an estimated $11.7M added.
  • The largest Collegium Pharmaceutical seller in Q3 2023 was Mesirow Institutional Investment Management, an estimated $9.37M sold.

Based on aggregated 13F filings for Q3 2023.